Secretory carcinoma of the breast: a report of six cases with different immunophenotypes and molecular subtypes
M. Ángeles López-García, L. Alfaro Galán, Blas Meléndez, B. Eizaguirre et autres
0 citationsHistopathology
Begoña Vieites
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
65Publications signalées
1073Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Breast Cancer Treatment StudiesBreast Lesions and CarcinomasOvarian cancer diagnosis and treatmentCancer Genomics and DiagnosticsCancer Cells and Metastasis
Publications récentes
Exosomal miRNA balance links estrogen receptor signaling to CDK4/6 inhibitor outcomes
Maria A Dominguez-Cejudo, Raquel Chapresto-Garzón, Ana Gil-Torralvo, María Ángeles Castilla et autres
0 citationsResearch Square
Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression
Isabel Miras Rodríguez, Ana Gil, Marta Benavent, María Ángeles Castilla et autres
8 citationsTherapeutic Advances in Medical Oncology
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
Marylène Lejeune, Laia Reverté, Noèlia Gallardo, Esther Sauras et autres
9 citationsInternational Journal of Molecular Sciences
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
David Pizarro, Ignacio Romero, Belén Perez‐Mies, Andrés Redondo et autres
8 citationsInternational Journal of Molecular Sciences
Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study
María D. Martín-Salvago, M. Ángeles López-García, Alicia Cano Jiménez, A. Pérez-Luque et autres
4 citationsBreast Cancer Research and Treatment
Abstract P1-04-18: Identification of UGT2B family genes as potential biomarkers of response to neoadjuvant therapy in HER2+ breast cancer
Ana Gil-Torralvo, Marta Benavent, Maria A Dominguez-Cejudo, Alejandro Falcón et autres
0 citationsCancer Research
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response
Marylène Lejeune, Laia Reverté, Esther Sauras, Noèlia Gallardo et autres
12 citationsCancers
Abstract P2-07-08: Identification of UGT2B15 as a potential biomarker in response to neoadjuvant therapy in HER2+ breast cancer
Ana Gil-Torralvo, Marta Benavent, Maria A Dominguez-Cejudo, Alejandro Falcón et autres
0 citationsCancer Research
65P Patient follow-up of NEOVATTL study
Begoña Vieites, M. Ángeles López‐García, María D. Martín-Salvago, César L. Ramírez-Tortosa et autres
0 citationsAnnals of Oncology
Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study
Begoña Vieites, M. Ángeles López‐García, María D. Martín-Salvago, César L. Ramírez-Tortosa et autres
19 citationsClinical & Translational Oncology
OC-0324: Prefoldin overexpression associates with the risk of mortality and metastasis in lung cancer
P. Romero Pareja, Silva Diego, Xenia Peñate, Jorge A Cantú Reyes et autres
0 citationsRadiotherapy and Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.